Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 11—November 2017
Research

Weather-Dependent Risk for Legionnaires’ Disease, United States

Jacob E. Simmering, Linnea A. Polgreen, Douglas B. Hornick, Daniel K. Sewell, and Philip M. PolgreenComments to Author 
Author affiliations: The University of Iowa, Iowa City, Iowa, USA

Main Article

Figure 2

Time series of Legionnaires’ disease as a percentage of bacterial pneumonia discharges in Healthcare Cost and Utilization Project hospitals, 26 US states, 1998–2011. The Legionnaires’ disease series is highly seasonal in the Northeast, Midwest, and South. There are very few cases and a lack of apparent seasonality in the West. The changes in the Legionnaires’ disease series after 2002–2003 may result from increased vigilance, testing, and reporting of atypical pneumonias (24).

Figure 2. Time series of Legionnaires’ disease as a percentage of bacterial pneumonia discharges in Healthcare Cost and Utilization Project hospitals, 26 US states, 1998–2011. The Legionnaires’ disease series is highly seasonal in the Northeast, Midwest, and South. There are few cases and a lack of apparent seasonality in the West. The changes in the Legionnaires’ disease series after 2002–2003 may result from increased vigilance, testing, and reporting of atypical pneumonias (24).

Main Article

References
  1. Fields  BS, Benson  RF, Besser  RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev. 2002;15:506–26. DOIPubMedGoogle Scholar
  2. Fine  MJ, Smith  MA, Carson  CA, Mutha  SS, Sankey  SS, Weissfeld  LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134–41. DOIPubMedGoogle Scholar
  3. Fraser  DW, Tsai  TR, Orenstein  W, Parkin  WE, Beecham  HJ, Sharrar  RG, et al. Legionnaires’ disease: description of an epidemic of pneumonia. N Engl J Med. 1977;297:1189–97. DOIPubMedGoogle Scholar
  4. von Baum  H, Ewig  S, Marre  R, Suttorp  N, Gonschior  S, Welte  T, et al.; Competence Network for Community Acquired Pneumonia Study Group. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis. 2008;46:1356–64. DOIPubMedGoogle Scholar
  5. Benin  AL, Benson  RF, Besser  RE. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis. 2002;35:1039–46. DOIPubMedGoogle Scholar
  6. Heath  CH, Grove  DI, Looke  DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis. 1996;15:286–90. DOIPubMedGoogle Scholar
  7. Gacouin  A, Le Tulzo  Y, Lavoue  S, Camus  C, Hoff  J, Bassen  R, et al. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med. 2002;28:686–91. DOIPubMedGoogle Scholar
  8. Jain  S, Self  WH, Wunderink  RG, Fakhran  S, Balk  R, Bramley  AM, et al.; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373:415–27. DOIPubMedGoogle Scholar
  9. Marchello  C, Dale  AP, Thai  TN, Han  DS, Ebell  MH. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis. Ann Fam Med. 2016;14:552–66. DOIPubMedGoogle Scholar
  10. Postma  DF, van Werkhoven  CH, van Elden  LJ, Thijsen  SF, Hoepelman  AI, Kluytmans  JA, et al.; CAP-START Study Group. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015;372:1312–23. DOIPubMedGoogle Scholar
  11. Fisman  DN, Lim  S, Wellenius  GA, Johnson  C, Britz  P, Gaskins  M, et al. It’s not the heat, it’s the humidity: wet weather increases legionellosis risk in the greater Philadelphia metropolitan area. J Infect Dis. 2005;192:2066–73. DOIPubMedGoogle Scholar
  12. Hicks  LA, Rose  CE Jr, Fields  BS, Drees  ML, Engel  JP, Jenkins  PR, et al. Increased rainfall is associated with increased risk for legionellosis. Epidemiol Infect. 2007;135:811–7. DOIPubMedGoogle Scholar
  13. Gleason  JA, Kratz  NR, Greeley  RD, Fagliano  JA. Under the weather: legionellosis and meteorological factors. EcoHealth. 2016;13:293–302. DOIPubMedGoogle Scholar
  14. Farnham  A, Alleyne  L, Cimini  D, Balter  S. Legionnaires’ disease incidence and risk factors, New York, New York, USA, 2002-2011. Emerg Infect Dis. 2014;20:1795–802. DOIPubMedGoogle Scholar
  15. Ricketts  KD, Charlett  A, Gelb  D, Lane  C, Lee  JV, Joseph  CA. Weather patterns and Legionnaires’ disease: a meteorological study. Epidemiol Infect. 2009;137:1003–12. DOIPubMedGoogle Scholar
  16. Karagiannis  I, Brandsema  P, VAN DER Sande  M. Warm, wet weather associated with increased Legionnaires’ disease incidence in The Netherlands. Epidemiol Infect. 2009;137:181–7. DOIPubMedGoogle Scholar
  17. Sabria  M, Alvarez  J, Dominguez  A, Pedrol  A, Sauca  G, Salleras  L, et al. A community outbreak of Legionnaires’ disease: evidence of a cooling tower as the source. Clin Microbiol Infect. 2006;12:642–7. DOIPubMedGoogle Scholar
  18. Katz  SM, Hammel  JM. The effect of drying, heat, and pH on the survival of Legionella pneumophila. Ann Clin Lab Sci. 1987;17:150–6.PubMedGoogle Scholar
  19. Beauté  J, Sandin  S, Uldum  SA, Rota  MC, Brandsema  P, Giesecke  J, et al. Short-term effects of atmospheric pressure, temperature, and rainfall on notification rate of community-acquired Legionnaires’ disease in four European countries. Epidemiol Infect. 2016;•••:1–11.PubMedGoogle Scholar
  20. Healthcare Cost and Utilization Project. NIS description of data elements. DXn–ICD-9-CM. General notes [cited 2017 Jun 27]. https://www.hcup-us.ahrq.gov/db/vars/dxn/nisnote.jsp
  21. Gershengorn  HB, Keene  A, Dzierba  AL, Wunsch  H. The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia. Clin Infect Dis. 2015;60:e66–79. DOIPubMedGoogle Scholar
  22. Centers for Disease Control and Prevention (CDC). Legionellosis --- United States, 2000-2009. MMWR Morb Mortal Wkly Rep. 2011;60:1083–6.PubMedGoogle Scholar
  23. Adams  DA, Thomas  KR, Jajosky  RA, Foster  L, Sharp  P, Onweh  DH, et al.; Nationally Notifiable Infectious Conditions Group. Summary of notifiable infectious diseases and conditions—United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;63:1–152. DOIPubMedGoogle Scholar
  24. Neil  K, Berkelman  R. Increasing incidence of legionellosis in the United States, 1990-2005: changing epidemiologic trends. Clin Infect Dis. 2008;47:591–9. DOIPubMedGoogle Scholar
  25. Stout  JE, Yu  VL, Best  MG. Ecology of Legionella pneumophila within water distribution systems. Appl Environ Microbiol. 1985;49:221–8.PubMedGoogle Scholar
  26. Mulazimoglu  L, Yu  VL. Can Legionnaires disease be diagnosed by clinical criteria? A critical review. Chest. 2001;120:1049–53. DOIPubMedGoogle Scholar
  27. Yu  VL, Plouffe  JF, Pastoris  MC, Stout  JE, Schousboe  M, Widmer  A, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis. 2002;186:127–8. DOIPubMedGoogle Scholar
  28. Helbig  JH, Uldum  SA, Bernander  S, Lück  PC, Wewalka  G, Abraham  B, et al. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires’ disease. J Clin Microbiol. 2003;41:838–40. DOIPubMedGoogle Scholar
  29. Mandell  LA, Wunderink  RG, Anzueto  A, Bartlett  JG, Campbell  GD, Dean  NC, et al.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. DOIPubMedGoogle Scholar
  30. Garin  N, Genné  D, Carballo  S, Chuard  C, Eich  G, Hugli  O, et al. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med. 2014;174:1894–901. DOIPubMedGoogle Scholar
  31. Neuhauser  MM, Weinstein  RA, Rydman  R, Danziger  LH, Karam  G, Quinn  JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA. 2003;289:885–8. DOIPubMedGoogle Scholar
  32. Davidson  R, Cavalcanti  R, Brunton  JL, Bast  DJ, de Azavedo  JC, Kibsey  P, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med. 2002;346:747–50. DOIPubMedGoogle Scholar
  33. Malhotra-Kumar  S, Lammens  C, Coenen  S, Van Herck  K, Goossens  H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007;369:482–90. DOIPubMedGoogle Scholar
  34. Fuller  JD, Low  DE. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis. 2005;41:118–21. DOIPubMedGoogle Scholar

Main Article

Page created: October 16, 2017
Page updated: October 16, 2017
Page reviewed: October 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external